The Pharmaceuticals will present comprehensive reviews of molecules that are drugs or active pharmacetical ingredients (API) in one-molecule/class per paper format, and research papers on molecular medicine. They will be published in two formats: pdf and html, both are openly accessible free of charge.

For review papers, the pdf versions and the corresponding html form of the papers will also be made available at the same time, but will continuously updated at http://www.mdpi.net/pharmaceuticals/ by the authors, who will be invited to add new literature, new comments and new paragraphs when relevant. These articles will thus be "living" reviews. Discussion forums will be set up for readers to comment on the reviews. New edition of the reviews can be published again in pdf if there is substantial revision with updated material. The title of the review can be the name of the pharmaceutical. Analogs of the durg and relevant derivatives of the compound can also be included. Papers should have an abstract and a list of keywords (The first keyword should be chosen from the list of drug classes). The main body of text should be arranged into the following sections: an Introduction giving a general survey of the area; a detailed review of the synthesis should also be given following the excellent review style of the journal Synthesis. This review can be very comprehensive, including all kinds of chemical and biological data regarding the discussed drug. There is no limit on the size of the review papers.

Authors and publishers are encouraged to send review copies of their recent related books to Dr. Shu-Kun Lin, MDPI Center, Matthaeusstrasse 11, CH-4057 Basel, Switzerland. Received books will be listed first as "Books Received", then offered to the scholarly community for preparing reviews.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is lin@mdpi.org.